SRI Krishna Pharmaceuticals Limited Tramadol Export Data — India (DGFT 2022–2026)

Name: SRI Krishna Pharmaceuticals Limited Tramadol Export Records India — #12 Exporter, 111 Shipments, $3.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Tramadol

India Pharmaceutical Trade Intelligence

$382.2M249 Suppliers103 CountriesHS 30049069

ExportsIndia → UNITED STATES62.1%India → NIGERIA12.3%

ImportsPHILIPPINES → India$5.4M GERMANY → India$16.1K

#1 Supplier: RUBICON RESEARCH #1 Buyer: EVERSANA LIFE

SRI Krishna Pharmaceuticals Limited — Tramadol Exporter #12 | $3.2M Trade Value | TransData Nexus | TransData Nexus

SRI Krishna Pharmaceuticals Limited — Tramadol Exporter Profile

Indian Pharmaceutical Exporter · #12 for Tramadol · $3.2M export value · DGFT Verified

SRI Krishna Pharmaceuticals Limited is the #12 Indian exporter of Tramadol with $3.2M in export value and 111 verified shipments. SRI Krishna Pharmaceuticals Limited holds a 0.8% market share in Tramadol exports across 1 countries. The company exports 6 pharmaceutical products worth $31.4M across 3 therapeutic categories.

SRI Krishna Pharmaceuticals Limited — Tramadol Export Profile: Buyers & Destinations

SRI Krishna Pharmaceuticals Limited Tramadol export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Tramadol?

Country	Value	Shipments	Share
UNITED STATES	$29.0M	580	26.0%
NIGERIA	$14.3M	286	12.8%
FRANCE	$12.5M	387	11.2%
SOUTH AFRICA	$9.8M	239	8.8%

Who Are the Top Buyers of Tramadol from India?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCES SERVICES LLC	UNITED STATES	$10.1M	202
SUBSTIPHARM	FRANCE	$6.8M	190
RXCROSSROADS 3PL LLC	UNITED STATES	$3.0M	61
APL SWIFT SERVICES (MALTA) LTD.,	MALTA	$2.7M	135
M/S. S B PHARMA GMBH	GERMANY	$2.6M	52
AMNEAL PHARMACEUTICALS, LLC	UNITED STATES	$2.3M	46
AMNEAL PHARMACEUTICALS LLC	UNITED STATES	$1.1M	23
AMB HK ENTERPRISES INC.	PHILIPPINES	$350.0K	7
XXNEAXXPHAXXACEXXICAXX LXX (NXX	UNITED STATES	$350.0K	7
ADPHARM, PHARMACEUTICAL INDUSTRIES	NIGERIA	$300.0K	6

India's Tramadol is purchased by 789 buyers worldwide. The top buyer is EVERSANA LIFE SCIENCES SERVICES LLC (UNITED STATES), followed by SUBSTIPHARM and RXCROSSROADS 3PL LLC.

How Does SRI Krishna Pharmaceuticals Limited Compare to Nearest Tramadol Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
11	AUROBINDO PHARMA LTD	$3.6M	183	4	$19.5K
4	REKVINA PHARMACEUTICALS	$3.3M	65	2	$50.0K
12	SRI KRISHNA PHARMACEUTICALS LIMITED ★	$3.2M	111	1	$28.8K
14	IPCA LABORATORIES LIMITED	$1.0M	20	6	$50.0K
15	REGAL LABORATORIES	$700.0K	14	4	$50.0K

SRI Krishna Pharmaceuticals Limited ranks #12 among 249 Indian Tramadol exporters. Average shipment value of $28.8K compared to the market average of $270.0K. The closest competitors by value are AUROBINDO PHARMA LTD and REKVINA PHARMACEUTICALS.

Which Indian Ports Ship Tramadol Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	463	11.8%
SAHAR AIR	405	10.3%
JNPT/ NHAVA SHEVA SEA	289	7.4%
SAHAR AIR CARGO ACC (INBOM4)	264	6.7%
JNPT	199	5.1%
MUNDRA SEA	150	3.8%
VIZAG SEA	108	2.7%
BANGALORE ICD	106	2.7%

Geopolitical & Trade Policy Impact on SRI Krishna Pharmaceuticals Limited's Tramadol Exports

Recent geopolitical tensions, notably the Israel-Iran conflict, have disrupted key shipping routes such as the Red Sea, leading to increased freight costs and extended transit times for Indian pharmaceutical exporters. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has highlighted potential losses ranging from ₹2,500 crore to ₹5,000 crore due to these disruptions. For SKPL, which relies on timely deliveries to maintain product efficacy, these logistical challenges necessitate strategic adjustments, including exploring alternative shipping routes and bolstering regional distribution networks.

In the US market, recent tariff implementations have introduced additional complexities for Indian exporters. While generic drugs have been exempted from certain tariffs, the overall trade environment remains uncertain. SKPL must remain vigilant, monitoring policy shifts and adapting its export strategies accordingly to maintain its competitive edge.

The India–EFTA Trade and Economic Partnership Agreement, effective from October 2025, presents new opportunities for SKPL in European markets. By eliminating or reducing tariffs on pharmaceutical products, the agreement facilitates smoother market entry, allowing SKPL to expand its footprint in EFTA member countries.

SRI Krishna Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with bodies like the US FDA increasing inspections to ensure compliance with Good Manufacturing Practices (GMP). India, hosting over 600 US FDA-approved manufacturing sites, faces ongoing challenges in maintaining consistent quality standards. Instances of substandard products have prompted calls for stricter oversight. For SKPL, maintaining rigorous quality control measures and staying abreast of evolving regulatory requirements are imperative to sustain its export credentials and market reputation.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Tramadol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SRI Krishna Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 103+ countries, 789+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Tramadol

Tramadol

SRI Krishna Pharmaceuticals Limited — Tramadol Exporter Profile

SRI Krishna Pharmaceuticals Limited — Tramadol Export Profile: Buyers & Destinations

Where Does India Export Tramadol?

Who Are the Top Buyers of Tramadol from India?

What Is India's Total Tramadol Export Value and How Much Does SRI Krishna Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for SRI Krishna Pharmaceuticals Limited's Tramadol Exports?

How Does SRI Krishna Pharmaceuticals Limited Compare to Other Indian Tramadol Exporters?

Regulatory Requirements: Exporting Tramadol to Key Markets

United States — FDA

Nigeria — NAFDAC

How Does SRI Krishna Pharmaceuticals Limited Compare to Nearest Tramadol Exporters?

Which Indian Ports Ship Tramadol Exports?

What Other Analgesics & Antipyretics Products Does SRI Krishna Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on SRI Krishna Pharmaceuticals Limited's Tramadol Exports

SRI Krishna Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About SRI Krishna Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Tramadol Export Data from SRI Krishna Pharmaceuticals Limited

Tramadol Stats

Company Overview

Top Products by SRI Krishna Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source